10th Parliament· 154 sittings on record · 30,475 speeches · latest 10 June 2026

Hon. (Dr.) S. Sri Bavanandarajah

Jathika Jana balawegaya· Jaffna· 21 October 2025 ·Debate: Debate: Regulations under National Medicines Regulatory Authority Act No. 5 of 2015

Cost of LivingHealthcare
AI summary generated by gpt-5.5

Hon. (Dr.) S. Sri Bavanandarajah called for stronger consumer awareness by making approved medicine lists and Maximum Retail Prices easily accessible online and in pharmacies. He urged closer coordination between the NMRA, State Pharmaceuticals Corporation and State Pharmaceuticals Manufacturing Corporation to ensure islandwide supply of affordable essential drugs, including through bulk purchasing and generic substitution. He requested support for legislative and administrative measures to strengthen the NMRA’s independence, modernize its operations and improve medicine price regulation.

Verbatim record (translated)

Machine-translated from Sinhala / Tamil / English

¶ 01 Sir, give me two more minutes, please.

¶ 02 Another vital step is strengthening consumer awareness. The public should have easy access to the list of approved medicines and their Maximum Retail Prices—published online and displayed at all pharmacies. Informed consumers are empowered consumers; that transparency will help drive prices down through competition and accountability.

¶ 03 Furthermore, the NMRA should collaborate closely with the State Pharmaceuticals Corporation and the State Pharmaceuticals Manufacturing Corporation to ensure continuous supply of essential drugs at affordable prices across the Island. Government bulk purchasing and generic substitution could further reduce costs to patients.

¶ 04 Sir, this is not merely an economic issue, but a moral imperative. The affordability of medicines directly affects the health, productivity and dignity of our people. We cannot allow a system where life-saving drugs are priced beyond the reach of those who need them most. Therefore, I urge this House to support the legislative and administrative measures needed to strengthen the NMRA, enhance its independence, modernize its operations and empower it to regulate medicine prices with fairness and firmness.

Provenance

Source
Hansard, Tuesday, 21 October 2025 ·No. 22635 ·English daily/uncorrected Hansard
Page · column
not yet extracted — page/column anchors are not in the current dataset; the source PDF is the citable location.
Permalink
/lk/speeches/29643

Cite as: Hon. (Dr.) S. Sri Bavanandarajah. 10th Parliament, Parliament of Sri Lanka. Hansard, 21 October 2025. No. 22635. Politick, https://staging.politick.io/lk/speeches/29643